These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 21395514)

  • 1. Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics.
    Jain AK; Das M; Swarnakar NK; Jain S
    Crit Rev Ther Drug Carrier Syst; 2011; 28(1):1-45. PubMed ID: 21395514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLGA Nanoparticles and Their Versatile Role in Anticancer Drug Delivery.
    Khan I; Gothwal A; Sharma AK; Kesharwani P; Gupta L; Iyer AK; Gupta U
    Crit Rev Ther Drug Carrier Syst; 2016; 33(2):159-93. PubMed ID: 27651101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
    Ravi Kumar MN; Bakowsky U; Lehr CM
    Biomaterials; 2004 May; 25(10):1771-7. PubMed ID: 14738840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLGA-based nanoparticles as cancer drug delivery systems.
    Sadat Tabatabaei Mirakabad F; Nejati-Koshki K; Akbarzadeh A; Yamchi MR; Milani M; Zarghami N; Zeighamian V; Rahimzadeh A; Alimohammadi S; Hanifehpour Y; Joo SW
    Asian Pac J Cancer Prev; 2014; 15(2):517-35. PubMed ID: 24568455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexation of Apoptotic Genes with Polyethyleneimine (PEI)-Coated Poly-(DL)-Lactic-Co-Glycolic Acid Nanoparticles for Cancer Cell Apoptosis.
    Lim HJ; Kim JK; Park JS
    J Biomed Nanotechnol; 2015 Feb; 11(2):211-25. PubMed ID: 26349297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro studies of PLGA-DTX nanoconjugate as potential drug delivery vehicle for oral cancer.
    Gupta P; Singh M; Kumar R; Belz J; Shanker R; Dwivedi PD; Sridhar S; Singh SP
    Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):67-69. PubMed ID: 29593398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives.
    Pandita D; Kumar S; Lather V
    Drug Discov Today; 2015 Jan; 20(1):95-104. PubMed ID: 25277320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents.
    Dinarvand R; Sepehri N; Manoochehri S; Rouhani H; Atyabi F
    Int J Nanomedicine; 2011; 6():877-95. PubMed ID: 21720501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable nanoparticles for drug and gene delivery to cells and tissue.
    Panyam J; Labhasetwar V
    Adv Drug Deliv Rev; 2003 Feb; 55(3):329-47. PubMed ID: 12628320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyelectrolyte coated polymeric nanoparticles for controlled release of docetaxel.
    Agrawal R; Shanavas A; Yadav S; Aslam M; Bahadur D; Srivastava R
    J Biomed Nanotechnol; 2012 Feb; 8(1):19-28. PubMed ID: 22515091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
    Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
    J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
    Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM
    Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLGA nanoparticles in drug delivery: the state of the art.
    Bala I; Hariharan S; Kumar MN
    Crit Rev Ther Drug Carrier Syst; 2004; 21(5):387-422. PubMed ID: 15719481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current advances in research and clinical applications of PLGA-based nanotechnology.
    Lü JM; Wang X; Marin-Muller C; Wang H; Lin PH; Yao Q; Chen C
    Expert Rev Mol Diagn; 2009 May; 9(4):325-41. PubMed ID: 19435455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic Consequences of PLGA Nanoparticles in Docetaxel Drug Delivery.
    Rafiei P; Haddadi A
    Pharm Nanotechnol; 2017; 5(1):3-23. PubMed ID: 28948907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomedical applications of PLGA nanoparticles in nanomedicine: advances in drug delivery systems and cancer therapy.
    Narmani A; Jahedi R; Bakhshian-Dehkordi E; Ganji S; Nemati M; Ghahramani-Asl R; Moloudi K; Hosseini SM; Bagheri H; Kesharwani P; Khani A; Farhood B; Sahebkar A
    Expert Opin Drug Deliv; 2023; 20(7):937-954. PubMed ID: 37294853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-Coated Poly(lactic-co-glycolic acid)-Diiodinated boron-Dipyrromethene Nanoparticles Improve Tumor Selectivity and Stealth Properties in Photodynamic Cancer Therapy.
    Voon SH; Tiew SX; Kue CS; Lee HB; Kiew LV; Misran M; Kamkaew A; Burgess K; Chung LY
    J Biomed Nanotechnol; 2016 Jul; 12(7):1431-52. PubMed ID: 29336539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.